* Indications: Travelers’ diarrhea: IDIBACT 200 mg is indicated for the treatment of patients (>/= 12 years of age) with Travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E.coli). * Limitation of Use: IDIBACT should not be used in patients with diarrhea complicated by fever or blood in the stool or diarrhea due to pathogens other than Escherichia coli (E.coli).
Bestsellers
المراجعات
لا توجد مراجعات بعد.